MIT Researchers Develop Wearable Ultrasound Patch That Could Replace Surgical Pacemakers
Key Insights
MIT engineers have created a stamp-sized wearable ultrasound patch that paces the heart noninvasively, eliminating the need for surgical pacemaker implantation.
The system combines a one-time gene therapy injection that sensitizes heart cells to sound with an external hydrogel patch that delivers targeted acoustic pulses.
In live rats with irregular heartbeats, the ultrasound patch safely restored steady rhythm for over eight months, and the technology was also successfully tested on pig hearts.
Regulating a misfiring heart has long required surgeons to permanently embed metal wires and batteries deep inside a patient's chest. Now, researchers at the Massachusetts Institute of Technology have discovered how to command cardiac rhythm from the outside using nothing but sound, potentially upending decades of cardiovascular consensus.
By genetically modifying cardiac tissue to "hear" targeted acoustic waves, the MIT team has developed a wearable, stamp-sized ultrasound sticker that successfully paces the heart without a single incision. Rather than implanting machinery to physically shock the muscle, clinicians could soon combine a one-time gene therapy injection with a simple external patch to manage arrhythmias (search).
The Burden of Surgical Pacemakers
Every year, surgeons worldwide implant roughly one million pacemakers to correct erratic heart rhythms. These battery-powered devices are embedded deep within the chest, where they deliver steadying electrical impulses directly to the heart muscle. While the treatment saves lives, the required surgery exposes patients to severe risks, including persistent infections, bleeding complications, and the inevitable physical degradation of the implanted hardware. Even the newest surgical advances cannot eliminate the hardware burden; patients still go home with a permanent machine lodged inside them.
"Pacemakers are one of the most important and widely used human implants, and they have saved millions of lives," says Gengxi Lu, a researcher at MIT and co-corresponding author of the study. "But they are invasive, and they make direct contact with the beating heart. The dream for many years has been noninvasive heart stimulation with ultrasound."
How Sonogenetics Enables Sound-Based Pacing
To make the heart actually listen to acoustic pulses, the team turned to a relatively new technique called sonogenetics. Much like optogenetics alters cells to react to light, sonogenetics genetically modifies cells so they respond to sound waves.
The engineers manipulated human heart cells to produce specific acoustic receptors, known as MscL-G22S ion channels (search). When ultrasound waves hit these engineered channels, they pop open and let calcium flood into the cell. That sudden rush of calcium is the trigger that forces the heart muscle to contract and beat. In the lab, engineered human heart cells beat in perfect rhythm with the ultrasound pulses, while unmodified cells simply ignored the sound.
The gene therapy does not alter a patient's DNA. Instead, it introduces RNA to make heart cells produce a sound-sensitive protein in the cell's ion channels. When stimulated, the ion channels admit calcium, which causes the heart to beat.
Preclinical Validation Across Species
To translate this technology to human patients, doctors would first administer a biological primer: a single gene-therapy injection, much like a vaccine, which instructs the heart muscle to build the necessary acoustic receptors.
The researchers proved the system works in live rats suffering from irregular heartbeats. After giving the animals the gene treatment, the team attached miniature ultrasound stickers to their chests. The acoustic waves rapidly restored a steady rhythm. The patch targeted tissue with extreme precision and safely regulated the animals' hearts during daily activities for over eight months. To ensure the technology scales up to human proportions, the engineers also successfully tested the device on large pig hearts.
In addition to the chest patch, the patient would need a data and power module that they could keep in their pocket, creating a fully external pacing system.
Toward a Closed-Loop Future
The MIT group now plans to combine this pacing patch with their earlier wearable sensors designed to image deep organs. This future device would act as a fully automated sentinel: continuously monitoring the heart, detecting any misfires, and instantly sending targeted ultrasound waves to correct the rhythm.
"We believe you could one day have stickers on the body that could do long-term imaging deep in the body and also do stimulation for therapeutic effects, in a noninvasive closed-loop way," says Xuanhe Zhao, a professor of mechanical engineering at MIT.